Treatment of Immunodeficiency with Interleukin‐2: Initial Exploration
作者:
Roland Mertelsmann,
Karl Welte,
Cora Sternberg,
Richard O'Reilly,
Malcolm Moore,
Bayard Clarkson,
Herbert Oettgen,
期刊:
Journal of Biological Response Modifiers
(OVID Available online 1984)
卷期:
Volume 3,
issue 5
页码: 483-490
ISSN:0732-6580
年代: 1984
出版商: OVID
关键词: Immunodeficiency;Interleukin‐2;Mitogens;Toxicity;Tumor response.
数据来源: OVID
摘要:
Summary:Fifteen patients with acquired immunodeficiency syndrome (AIDS), lymphoma and immunodeficiency, or severe combined immunodeficiency were treated with highly purified interleukin‐2 (IL‐2) prepared from human lymphocytes. All patients showed a defect in mitogen‐induced T cell proliferation which was partially corrected when IL‐2 was addedin vitro.IL‐2 was administered subcutaneously by daily injection or continuous infusion. The maximum daily dose was 20,000 U/m2, the maximum total dose 855,000 U/m2, and the maximum period of treatment 77 days. An increase in the platelet count was seen in one patient with AIDS, a decrease in the serum level of a monoclonal immunoglobulin in another patient with AIDS, and a minor tumor response in a patient with diffuse histiocytic lymphoma. As no toxicity was observed, further study of IL‐2 in the treatment of human immunodeficiency is indicated.
点击下载:
PDF
(3412KB)
返 回